Latest filings (excl ownership)
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
424B3
Prospectus supplement
13 Jun 24
6-K
Current report (foreign)
12 Jun 24
6-K
XORTX to Present at BIO International Convention 2024
4 Jun 24
6-K
Current report (foreign)
17 May 24
6-K
Condensed Interim Consolidated Financial Statements
16 May 24
20-F
2023 FY
Annual report (foreign)
10 May 24
NT 20-F
Notice of late annual filing (foreign)
1 May 24
6-K
Current report (foreign)
30 Apr 24
6-K
XORTX Announces Publication of Key Research in ADPKD
22 Apr 24
6-K
XORTX Welcomes New Member to the Board of Directors
8 Apr 24
6-K
XORTX Announces Participation in Spring 2024 Investor Conferences
8 Apr 24
6-K
XORTX Announces New Clinical Advisory Board Member
27 Mar 24
6-K
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
19 Mar 24
6-K
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
3 Jan 24
6-K
XORTX Welcomes New Member to the Board of Directors
2 Jan 24
6-K
XORTX Announces US ATM Offering
30 Nov 23
6-K
XORTX Announces US ATM Offering
30 Nov 23
424B5
Prospectus supplement for primary offering
29 Nov 23
6-K
Current report (foreign)
29 Nov 23
6-K
Condensed Interim Consolidated Financial Statements
15 Nov 23
6-K
Current report (foreign)
13 Nov 23
6-K
XORTX Announces Share Consolidation
8 Nov 23
6-K
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023
2 Nov 23
6-K
XORTX Announces Results of Special Meeting of Shareholders
27 Oct 23
6-K
Current report (foreign)
27 Oct 23
6-K
XORTX Announces Date for Rescheduled Special Meeting of Shareholders
25 Oct 23
6-K
XORTX Announces Rescheduling of Special Meeting of Shareholders
25 Oct 23
6-K
XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution
12 Oct 23
6-K
XORTX Calls Special Meeting of Shareholders
4 Oct 23
Latest ownership filings